Nuwellis Inc NUWE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Nuwellis to Report Third Quarter 2026 Financial Results on November 12
-
Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric Nephrology
-
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System
-
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
-
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
-
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
-
Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins
-
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
Trading Information
- Previous Close Price
- $5.91
- Day Range
- $5.20–5.56
- 52-Week Range
- $2.52–1,556.07
- Bid/Ask
- $5.09 / $5.40
- Shares Outstanding
- 405,252.00
- Market Cap
- $2.14M
- Volume/Avg
- 80,588 / 872,069
Key Statistics
- Price/Earnings (Normalized)
- 0.00
- Price/Sales
- 0.01
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 38
- Website
- https://www.nuwellis.com
Valuation
|
Metric
|
NUWE
|
|---|---|
Price/Earnings (Normalized) | 0.00 |
Price/Book Value | — |
Price/Sales | 0.01 |
Price/Cash Flow | — |
Price/Earnings
NUWE
Financial Strength
|
Metric
|
NUWE
|
|---|---|
Quick Ratio | 1.36 |
Current Ratio | 1.97 |
Interest Coverage | −0.86 |
Quick Ratio
NUWE
Profitability
|
Metric
|
NUWE
|
|---|---|
Return on Assets (Normalized) | −239.45% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
NUWE
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|!@LG<@D | LOCK|pQ!mN | $189B | |||
| Medtronic PLC
MDT
| LOCK|<F^r#cs | LOCK|FxCm | $126B | |||
| Stryker Corp
SYK
| LOCK|!<%v&Y# | LOCK|D#% | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|hc^P%H! | LOCK|wQQv | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|R#v<<&># | LOCK|B$>kR | $55B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|sCPvTRG | LOCK|&<s | $36B | |||
| DexCom Inc
DXCM
| LOCK|Lgh^wmF | LOCK|RZHn | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|PXV | LOCK|B$ | $28B | |||
| Steris PLC
STE
| LOCK|d#T#WR& | LOCK|>g@Xj | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|$BtV$DP< | LOCK|j&Q | $19B |
United States